Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study

Background: Until recently, the lack of clinical outcomes information for rheumatoid arthritis (RA) in administrative claims databases limited their use in comparative effectiveness research. A validated claims-based algorithm has been developed to estimate the effectiveness of biologics for RA, all...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Tao, Shah, Neel, Deshpande, Gaurav, Tang, Derek H., Eisenberg, Debra F., Harrison, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2015
Materias:
Autoimmune Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471369/
https://www.ncbi.nlm.nih.gov/pubmed/37663319
http://dx.doi.org/10.36469/9830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471369/
https://www.ncbi.nlm.nih.gov/pubmed/37663319
http://dx.doi.org/10.36469/9830

Ejemplares similares